Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022016
Company: CUMBERLAND PHARMS

Products on NDA 022016

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
VAPRISOL	CONIVAPTAN HYDROCHLORIDE	20MG	INJECTABLE; INJECTION	Prescription	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022016

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/28/2007	ORIG-1	Approval	Type 6 - New Indication (no longer used)	STANDARD	Letter (PDF) Review	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/022016s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2007/022016_vaprisol_toc.cfm